Banque Cantonale Vaudoise Buys 1,547 Shares of McKesson Corporation $MCK

Banque Cantonale Vaudoise increased its stake in shares of McKesson Corporation (NYSE:MCK) by 24.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,992 shares of the company’s stock after purchasing an additional 1,547 shares during the period. Banque Cantonale Vaudoise’s holdings in McKesson were worth $6,556,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in MCK. GGM Financials LLC purchased a new stake in McKesson during the third quarter valued at $25,000. State of Wyoming bought a new position in shares of McKesson in the 2nd quarter worth approximately $29,000. Hopwood Financial Services Inc. bought a new position in shares of McKesson in the 3rd quarter worth approximately $31,000. Vermillion & White Wealth Management Group LLC purchased a new position in shares of McKesson in the third quarter worth approximately $33,000. Finally, Board of the Pension Protection Fund bought a new stake in McKesson during the fourth quarter valued at approximately $33,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.

Insider Buying and Selling

In other McKesson news, Director Maria Martinez sold 349 shares of McKesson stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $939.87, for a total value of $328,014.63. Following the sale, the director owned 301 shares of the company’s stock, valued at $282,900.87. The trade was a 53.69% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Michele Lau sold 2,725 shares of the stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $990.00, for a total value of $2,697,750.00. Following the transaction, the executive vice president owned 3,247 shares of the company’s stock, valued at $3,214,530. This represents a 45.63% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.08% of the stock is currently owned by corporate insiders.

McKesson Stock Down 1.7%

NYSE:MCK opened at $762.50 on Wednesday. The business’s 50-day simple moving average is $848.60 and its two-hundred day simple moving average is $857.00. McKesson Corporation has a 52 week low of $637.00 and a 52 week high of $999.00. The stock has a market cap of $91.65 billion, a PE ratio of 19.82, a P/E/G ratio of 1.16 and a beta of 0.35.

McKesson (NYSE:MCK) last issued its earnings results on Thursday, May 7th. The company reported $11.69 earnings per share for the quarter, topping analysts’ consensus estimates of $11.56 by $0.13. The firm had revenue of $96.30 billion during the quarter, compared to analyst estimates of $101.35 billion. McKesson had a net margin of 1.18% and a negative return on equity of 345.35%. McKesson’s revenue for the quarter was up 6.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $10.12 earnings per share. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. Sell-side analysts anticipate that McKesson Corporation will post 44.29 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 1st. Investors of record on Monday, June 1st will be given a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date is Monday, June 1st. McKesson’s payout ratio is currently 8.53%.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Weiss Ratings reiterated a “buy (b+)” rating on shares of McKesson in a research report on Monday, May 4th. Wall Street Zen upgraded McKesson from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. JPMorgan Chase & Co. decreased their target price on McKesson from $1,107.00 to $1,015.00 and set an “overweight” rating on the stock in a report on Friday, May 8th. Wells Fargo & Company lowered their target price on McKesson from $925.00 to $812.00 and set an “equal weight” rating on the stock in a research report on Tuesday, May 12th. Finally, Evercore restated an “outperform” rating on shares of McKesson in a research report on Thursday, March 5th. Fourteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $968.87.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.